Total Payments
$791.80
2024 Payments
$309.34
Companies
8
Transactions
22
Medicare Patients
17,838
Medicare Billing
$1.7M
Payment Breakdown by Category
Education$457.51 (57.8%)
Food & Beverage$154.29 (19.5%)
Other$130.00 (16.4%)
Research$50.00 (6.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $457.51 | 6 | 57.8% |
| Food and Beverage | $154.29 | 13 | 19.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $130.00 | 2 | 16.4% |
| Unspecified | $50.00 | 1 | 6.3% |
Payments by Type
General
$741.80
21 transactions
Research
$50.00
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $446.99 | 5 | $0 (2024) |
| GENZYME CORPORATION | $90.00 | 1 | $0 (2019) |
| GlaxoSmithKline, LLC. | $86.52 | 4 | $0 (2024) |
| Allergan Inc. | $48.38 | 4 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $40.00 | 1 | $0 (2021) |
| Lilly USA, LLC | $32.52 | 2 | $0 (2024) |
| PFIZER INC. | $23.99 | 2 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $23.40 | 3 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $309.34 | 7 | Astellas Pharma US Inc ($249.99) |
| 2023 | $98.00 | 1 | Astellas Pharma US Inc ($98.00) |
| 2021 | $63.40 | 4 | SANOFI-AVENTIS U.S. LLC ($40.00) |
| 2019 | $125.30 | 4 | GENZYME CORPORATION ($90.00) |
| 2018 | $36.24 | 3 | Allergan Inc. ($23.88) |
| 2017 | $159.52 | 3 | Astellas Pharma US Inc ($99.00) |
All Payment Transactions
22 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/10/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: Diabetes | ||||||
| 08/30/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: RESPIRATORY | ||||||
| 05/23/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $75.00 | General |
| 04/10/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: Diabetes | ||||||
| 04/04/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $95.00 | General |
| 04/04/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $79.99 | General |
| 01/24/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: VACCINES | ||||||
| 08/03/2023 | Astellas Pharma US Inc | — | Education | In-kind items and services | $98.00 | General |
| 12/09/2021 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $40.00 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/30/2021 | Sunovion Pharmaceuticals Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $9.60 | General |
| Category: UROLOGY | ||||||
| 11/16/2021 | Sunovion Pharmaceuticals Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $6.90 | General |
| Category: UROLOGY | ||||||
| 11/16/2021 | Sunovion Pharmaceuticals Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $6.90 | General |
| Category: UROLOGY | ||||||
| 09/04/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $10.80 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 04/25/2019 | GENZYME CORPORATION | SOLIQUA 100/33 (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $90.00 | General |
| Category: DIABETES | ||||||
| 03/12/2019 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $12.13 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/12/2019 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $12.37 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/13/2018 | Allergan Inc. | LASTACAFT (Drug) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/01/2018 | Allergan Inc. | BYSTOLIC (Drug) | Food and Beverage | In-kind items and services | $10.80 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/12/2018 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $12.36 | General |
| Category: RESPIRATORY | ||||||
| 11/28/2017 | GlaxoSmithKline, LLC. | — | Education | In-kind items and services | $10.52 | General |
| 11/10/2017 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.00 | General |
| 02/08/2017 | GlaxoSmithKline, LLC. | — | — | Cash or cash equivalent | $50.00 | Research |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 34 | 4,056 | 7,056 | $733,640 | $367,929 |
| 2022 | 34 | 4,353 | 8,734 | $901,515 | $446,424 |
| 2021 | 35 | 4,558 | 9,698 | $842,778 | $468,997 |
| 2020 | 38 | 4,871 | 9,668 | $793,759 | $432,861 |
Total Patients
17,838
Total Services
35,156
Medicare Billing
$1.7M
Procedure Codes
141
All Medicare Procedures & Services
141 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 527 | 1,437 | $208,675 | $92,713 | 44.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 470 | 470 | $90,740 | $63,309 | 69.8% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 113 | 707 | $70,700 | $35,743 | 50.6% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 100 | 132 | $55,020 | $30,415 | 55.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 182 | 243 | $48,025 | $24,251 | 50.5% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 108 | 559 | $48,060 | $21,696 | 45.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 59 | 59 | $19,990 | $9,864 | 49.3% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 515 | 515 | $20,600 | $9,597 | 46.6% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 498 | 498 | $19,920 | $9,243 | 46.4% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 22 | 229 | $15,145 | $7,368 | 48.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 221 | 222 | $11,100 | $7,120 | 64.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 141 | 192 | $17,280 | $6,893 | 39.9% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 25 | 145 | $11,600 | $5,738 | 49.5% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 85 | 86 | $12,900 | $5,657 | 43.8% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 155 | 196 | $8,820 | $5,048 | 57.2% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2023 | 218 | 219 | $7,665 | $4,481 | 58.5% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 22 | 106 | $9,725 | $4,417 | 45.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 65 | 75 | $8,250 | $3,582 | 43.4% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 17 | 19 | $6,175 | $3,185 | 51.6% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 17 | 17 | $4,590 | $2,922 | 63.7% |
| 99491 | Chronic care management services for two or more chronic conditions, first 30 minutes provided personally by health care professional, per calendar month | Office | 2023 | 33 | 37 | $4,995 | $2,580 | 51.6% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 52 | 59 | $5,310 | $2,501 | 47.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 61 | 155 | $4,805 | $1,676 | 34.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $3,380 | $1,374 | 40.7% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 23 | 27 | $4,050 | $1,270 | 31.4% |
About Dr. Tushar Modi, M.D
Dr. Tushar Modi, M.D is a Internal Medicine healthcare provider based in Modesto, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1679551352.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Tushar Modi, M.D has received a total of $791.80 in payments from pharmaceutical and medical device companies, with $309.34 received in 2024. These payments were reported across 22 transactions from 8 companies. The most common payment nature is "Education" ($457.51).
As a Medicare-enrolled provider, Modi has provided services to 17,838 Medicare beneficiaries, totaling 35,156 services with total Medicare billing of $1.7M. Data is available for 4 years (2020–2023), covering 141 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Geriatric Medicine
- Location Modesto, CA
- Active Since 01/04/2006
- Last Updated 01/01/2026
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1679551352
Products in Payments
- SOLIQUA 100/33 (Drug) $90.00
- TOUJEO (Biological) $40.00
- MOUNJARO (Drug) $32.52
- LINZESS (Drug) $24.50
- GEMTESA (Drug) $23.40
- TRELEGY ELLIPTA (Drug) $13.64
- PREVNAR 20 (Biological) $13.19
- LASTACAFT (Drug) $13.08
- ANORO (Drug) $12.36
- BYSTOLIC (Drug) $10.80
- CHANTIX (Drug) $10.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Modesto
Wen Han, M.d, M.D
Internal Medicine — Payments: $131,277
Internal Medicine $131,277
Robert Tanaka, M.d, M.D
Internal Medicine — Payments: $42,946
Internal Medicine $42,946
Dat Do, M.d, M.D
Internal Medicine — Payments: $23,083
Internal Medicine $23,083
Dr. Talwinderdeep Kahlon, M.d, M.D
Internal Medicine — Payments: $13,710
Internal Medicine $13,710
Dr. Priti Modi, M.d., F.a.c.p, M.D., F.A.C.P
Internal Medicine — Payments: $10,257
Internal Medicine $10,257
Lily Park, D.o, D.O
Internal Medicine — Payments: $9,808
Internal Medicine $9,808